BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26258612)

  • 1. The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal Neovascularization.
    Van Bergen T; Spangler R; Marshall D; Hollanders K; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5280-9. PubMed ID: 26258612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of LOX and LOXL2 in scar formation after glaucoma surgery.
    Van Bergen T; Marshall D; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5788-96. PubMed ID: 23821193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic effect of the basement membrane protein nidogen-1 in a mouse model of choroidal neovascularization.
    Semkova I; Kociok N; Karagiannis D; Nischt R; Smyth N; Paulsson M; Strauß O; Joussen AM
    Exp Eye Res; 2014 Jan; 118():80-8. PubMed ID: 24280453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose induced differential expression of lysyl oxidase and its isoform in ARPE-19 cells.
    Coral K; Madhavan J; Pukhraj R; Angayarkanni N
    Curr Eye Res; 2013 Jan; 38(1):194-203. PubMed ID: 22966818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiostatic effect of CXCR3 expressed on choroidal neovascularization.
    Fujimura S; Takahashi H; Yuda K; Ueta T; Iriyama A; Inoue T; Kaburaki T; Tamaki Y; Matsushima K; Yanagi Y
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1999-2006. PubMed ID: 22408007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal regulation of LOX and LOXL2 expression during cell adhesion and terminal differentiation in epidermal keratinocytes.
    Fujimoto E; Tajima S
    J Dermatol Sci; 2009 Aug; 55(2):91-8. PubMed ID: 19394199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells.
    Kim EC; Lee HJ; Kim Y
    J Endod; 2012 Jun; 38(6):769-73. PubMed ID: 22595110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
    Zaffryar-Eilot S; Marshall D; Voloshin T; Bar-Zion A; Spangler R; Kessler O; Ghermazien H; Brekhman V; Suss-Toby E; Adam D; Shaked Y; Smith V; Neufeld G
    Carcinogenesis; 2013 Oct; 34(10):2370-9. PubMed ID: 23828904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive retinol intake exacerbates choroidal neovascularization through upregulated vascular endothelial growth factor in retinal pigment epithelium in mice.
    Tan X; Takahashi H; Nishida J; Aoki A; Inoue T; Yanagi Y
    Exp Eye Res; 2015 Feb; 131():77-83. PubMed ID: 25576666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
    Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
    Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat].
    Zhao SH; He SZ; Shi XH
    Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):522-7. PubMed ID: 15454039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
    Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascularization in a laser-induced mouse model.
    Zhang ZX; Wang YS; Shi YY; Hou HY; Zhang C; Cai Y; Dou GR; Yao LB; Li FY
    Curr Eye Res; 2011 Sep; 36(9):838-49. PubMed ID: 21851170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
    Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
    Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
    Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
    Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization.
    Mochimaru H; Takahashi E; Tsukamoto N; Miyazaki J; Yaguchi T; Koto T; Kurihara T; Noda K; Ozawa Y; Ishimoto T; Kawakami Y; Tanihara H; Saya H; Ishida S; Tsubota K
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4410-5. PubMed ID: 19339747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.